The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Immune-related tumor response dynamics in melanoma patients (pts) treated with pembrolizumab: Identifying markers for clinical outcome and treatment decisions.
 
Mizuki Nishino
Honoraria - Bayer Yakuhin
Consulting or Advisory Role - Toshiba; WorldCare Clinical, LLC
Research Funding - Merck (Inst)
 
Anita Giobbie-Hurder
No Relationships to Disclose
 
Michael P Manos
No Relationships to Disclose
 
Nancy Bailey
No Relationships to Disclose
 
Elizabeth Iannotti Buchbinder
Employment - Merck (I)
Consulting or Advisory Role - Castle Biosciences; Checkmate Pharmaceuticals; Immune Design
 
Patrick Alexander Ott
Consulting or Advisory Role - Alexion Pharmaceuticals; Amgen; Bristol-Myers Squibb; Celldex; CytomX Therapeutics; Genentech; Neon Therapeutics
Research Funding - ARMO BioSciences (Inst); AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Celldex (Inst); Merck (Inst)
 
Nikhil H. Ramaiya
No Relationships to Disclose
 
F. Stephen Hodi
Employment - Dana-Farber Cancer Institute
Consulting or Advisory Role - Amgen; EMD Serono; Genentech/Roche; Merck Sharp & Dohme; Novartis
Research Funding - bristol-myers squibb (Inst); Genentech/Roche (Inst); Merck Sharp & Dohme (Inst); novartis (Inst)
Patents, Royalties, Other Intellectual Property - patent pending as per institutional policy; patent pending royalties received on MICA related disorders application to institution per institutional IP policy
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Novartis
Other Relationship - Bristol-Myers Squibb; Genentech/Roche